The systems and kits are accompanied by the information mentioned in Article R. 5211-22, including, where applicable, the information supplied by the manufacturers of the devices that have been assembled. They do not have to carry an additional CE marking.
Prescriptions for medical devices issued at the request of a patient with a view to obtaining a supply in another Member State of the European Union must include the following information: 1° The surname and forenames, position and, where applicable, the title or speciality of the prescriber, his professional address specifying “France”, his telephone number preceded by the international dialling code “+ 33” and his e-mail address, his signature, as…
When the prescription includes the information provided for in 1°, subject to adaptation of the country information, to 3° of Article R. 5211-70, persons legally authorised to supply medical devices may refuse to supply these products, prescribed in another Member State of the European Union by a healthcare professional legally authorised or empowered to prescribe medical devices in that State, only if it appears to them that the interests of…
The purpose of materiovigilance is to monitor incidents or risks of incidents resulting from the use of medical devices which are defined in article L. 5211-1 and come under this title by virtue of articles R. 5211-1 to R. 5211-3. It is carried out on medical devices after they have been placed on the market.
Materiovigilance involves : 1° Reporting and recording the incidents or risks of incidents mentioned in articles R. 5212-14 and R. 5212-15; 2° Recording, evaluating and using this information for prevention purposes; 3° Carrying out any studies or work relating to the safe use of medical devices; 4° Carrying out and monitoring any corrective action decided upon.
The exercise of material vigilance may involve, in addition to the communication by the manufacturer of the documents mentioned in Article R. 5211-26, access to data in the pre-clinical experimental file and to data relating to clinical investigations, in particular the report on clinical investigations mentioned in Article R. 5211-37 and the information listed in Article R. 5211-38, as well as access to information relating to the design, manufacture, storage,…
The Director General of the Agence nationale de sécurité du médicament et des produits de santé (French National Agency for the Safety of Medicines and Health Products) carries out his duties relating to material vigilance under the conditions defined in Article R. 5311-2 and ensures compliance with the monitoring procedures organised by this chapter. It informs the manufacturer(s) concerned when the facts reported are brought to its attention by a…
The Director General of the Agence nationale de sécurité du médicament et des produits de santé shall inform without delay of any incident or risk of incident defined in Article L. 5212-2: the Etablissement Français du Sang (French Blood Establishment), with regard to medical devices used in the collection, manufacture and administration of blood-derived products; -the Agence de la biomédecine, for medical devices used in the collection, processing, preservation and…
The regional material vigilance and reactovigilance coordinators carry out their vigilance duties under the conditions defined in article R. 1413-61-4.
Any health establishment or health cooperation group which uses or supplies medical devices or makes such devices available to its members, as well as any association distributing medical devices at home and appearing on a list drawn up by the Director General of the Agence nationale de sécurité du médicament et des produits de santé, must appoint a local materialovigilance correspondent. However, below an activity threshold set by order of…
Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call us at +33 (0) 1 84 88 31 00 or send us an email.
is a Registered Trademark of
PETROFF LAW FIRM (SELARL LEGASTRAT)
182, rue de Rivoli
75001, Paris France
RCS Paris n°814433470
Paris Bar Registration n° (Toque) C2396
is a Registered Trademark of
PETROFF LAW FIRM (SELARL LEGASTRAT)
182, rue de Rivoli
75001, Paris France
RCS Paris n°814433470
Paris Bar Registration n° (Toque) C2396
Resources
is a Registered Trademark of
PETROFF LAW FIRM (SELARL LEGASTRAT)
182, rue de Rivoli
75001, Paris France
RCS Paris n°814433470
Paris Bar Registration n° (Toque) C2396
Useful links
Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call +33 (0) 1 84 88 31 00 or send us an email.
All information exchanged through this website will be communicated to lawyers registered with a French Bar and will remain confidential.
